🇺🇸 FDA
Pipeline program

Claseprubart

DNTH103-MMN-201

Phase 2 small_molecule active

Quick answer

Claseprubart for Multifocal Motor Neuropathy is a Phase 2 program (small_molecule) at Dianthus Therapeutics, Inc. /DE/ with 1 ClinicalTrials.gov record(s).

Program details

Company
Dianthus Therapeutics, Inc. /DE/
Indication
Multifocal Motor Neuropathy
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials